Merck beats AstraZeneca to first approval for first PCSK9 pillnews2026-07-16T10:45:08+00:00July 16th, 2026|Endpoints News|
FDA acting chief walks back Makary’s practice of policymaking through journalsnews2026-07-15T19:21:40+00:00July 15th, 2026|Endpoints News|
Senate committee questions CDC pick on political interference over vaccinesnews2026-07-15T18:46:12+00:00July 15th, 2026|Endpoints News|
J&J restructures pharma manufacturing footprint at cost of up to $750M news2026-07-15T16:48:54+00:00July 15th, 2026|Endpoints News|
Eli Lilly invests in Oura to support patients on GLP-1 drugsnews2026-07-15T16:33:11+00:00July 15th, 2026|Endpoints News|
Radiopharma maker AdvanCell hauls in $315M for Pluvicto challengernews2026-07-15T15:25:34+00:00July 15th, 2026|Endpoints News|
J&J touts Icotyde prescriptions, but not sales, in first full quarternews2026-07-15T14:35:54+00:00July 15th, 2026|Endpoints News|
Nava Therapeutics emerges with $89M for lipid nanoparticlesnews2026-07-15T13:00:03+00:00July 15th, 2026|Endpoints News|
Braveheart files for IPO to fund Phase 3 of Hengrui’s Cytokinetics rivalnews2026-07-15T12:52:00+00:00July 15th, 2026|Endpoints News|
Insilico, Bora Pharma reveal plans for AI-driven manufacturing companynews2026-07-15T12:30:44+00:00July 15th, 2026|Endpoints News|